SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-353220
Filing Date
2018-12-19
Accepted
2018-12-19 16:00:03
Documents
2
Effectiveness Date
2018-12-19

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d674882d8k.htm DEFA14A 45288
2 EX-10.1 d674882dex101.htm EX-10.1 74898
  Complete submission text file 0001193125-18-353220.txt   121397
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35405 | Film No.: 181243492
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences